|
|||||
|
|
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low‐risk patient as defined by targeted sequencing |
|
| Authors: | Brittny N. Tillman MD Megan Yanik BS Andrew C. Birkeland MD Chia‐Jen Liu MS Daniel H. Hovelson MS Andi K. Cani MS Nallasivam Palanisamy PhD Shannon Carskadon MS Thomas E. Carey PhD Carol R. Bradford MD Scott A. Tomlins MD PhD Jonathan B. McHugh MD Matthew E. Spector MD J. Chad Brenner PhD |
| Affiliation: | 1. Department of Otolaryngology–Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan;2. Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan;3. Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan;4. Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan;5. Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan |
| Abstract: | |
| Keywords: | head and neck squamous cell carcinoma (HNSCC) fibroblast growth factor (FGF) fibroblast growth factor receptor (FGFR) amplification mutant |